Chang, Betty Y <br/><br/>
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.  [electronic resource] 

 -  Arthritis research & therapy  Jul 2011 
 - R115 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar3400  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Agammaglobulinaemia Tyrosine Kinase<br/>Animals<br/>Arthritis, Experimental--immunology<br/>Arthritis, Rheumatoid--immunology<br/>B-Lymphocytes--drug effects<br/>Cell Proliferation--drug effects<br/>Female<br/>Humans<br/>Immune Complex Diseases--immunology<br/>Macrophages--drug effects<br/>Mast Cells--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Monocytes--drug effects<br/>Piperidines<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology